Discovering pathways in benign prostate hyperplasia: A functional genomics pilot study

Area of Science:

• Urology
• Bioinformatics
• Computational Biology

Background:

• Benign prostate hyperplasia (BPH) is a common condition in aging males, causing urinary issues and potentially severe complications.
• Limited histopathological and clinical knowledge exists regarding BPH.
• Aging males are increasingly affected by BPH, leading to a rise in associated mortality.

Purpose of the Study:

• To utilize an in silico approach for discovering protein-protein interactions and prognostic biomarkers for BPH.
• To identify differentially expressed genes and analyze their functional clusters and interaction networks in BPH.
• To explore potential therapeutic agents, including Chinese herbal medicines, for BPH treatment through molecular docking.

Main Methods:

• Genome-scale microarray expression data analysis to identify differentially expressed genes in BPH.
• Gene annotation, functional clustering, and interaction network analysis.
• Molecular docking simulations of identified BPH gene biomarkers with potential therapeutic compounds.

Main Results:

• Identification of various differentially expressed genes associated with BPH.
• Functional annotation and interaction analysis revealed key pathways and disease phenotypes.
• Molecular docking indicated that berberine forms the most stable complex with the AGR2 receptor (PDB ID: 2LNT).

Conclusions:

• The study successfully identified potential prognostic biomarkers and interaction networks for BPH using bioinformatics.
• Berberine (Huang Bo) shows potential as a therapeutic agent for BPH, warranting further pharmacological investigation.
• The findings contribute to a better understanding of BPH pathogenesis and offer new avenues for treatment development.